505(b)(2)
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
64
NCT03363763
Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 12, 2017
Completion: Mar 24, 2023
NCT03239353
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects
Phase: Phase 1
Start: Oct 20, 2017
Completion: Jun 20, 2018
Loading map...